Latest Updates of Companies in the Prescription Digital Therapeutics Market
| Company | Headquarters | Latest Update |
| Akili, Inc. | United States | Akili is a digital therapeutics organization that provides advanced video game-based therapies for neurological and psychiatric conditions. |
| Click Therapeutics | United States | In April 2026, Click Therapeutics received a $50 million Series D investment from Boehringer Ingelheim to commercialize CT-155, an investigational digital healing for schizophrenia. |
| Big Health | United States | In February 2026, Big Health, a foremost developer of digital treatments for the most pervasive mental health conditions, announced a novel round of strategic funding of $23.7M to hasten access to its FDA-cleared, reimbursable solutions. |
| Omada Health | United States | In November 2025, Omada launched prescribing and medication management for anti-obesity medicines (AOMs), involving GLP-1s, providing members with behavioral coaching alongside clinical treatment. |
| WellDoc | United States | In May 2026, Welldoc, an AI-driven health technology leader, announced that it had been named the winner of the Best Overall Digital Health Organization award for the fourth consecutive year in the MedTech Breakthrough Awards. |
Recent Developments in the Prescription Digital Therapeutics Market
- In July 2025, the Food and Drug Administration (FDA) granted marketing authorization to CT-132, a prescription digital therapeutic developed by Click Therapeutics, for the defensive treatment of episodic migraine in adults.
- In May 2025, AMCP applauded the introduction of the Access to Prescription Digital Therapeutics Act of 2025 by Senators Shelley Moore Capito (R-WV) and Jeanne Shaheen (D-NH) and Representatives Kevin Hern and Mike Thompson.
Market Growth
The global prescription digital therapeutics market size was estimated at USD 4.82 billion in 2025 and is predicted to increase from USD 5.92 billion in 2026 to approximately USD 37.59 billion by 2035, expanding at a CAGR of 22.8% from 2026 to 2035.
Keypoints
- Company Overview
- Locations Subsidiaries/Geographic reach
- Key Executives
- Company Financials
- Patents registered
- SWOT Analysis
- Applications Catered
- Strategic collaborations
- Recent Developments
- Competitive Benchmarking